Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
about
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Cerebral venous thrombosis after immune thrombocytopenic purpura and anti-D immune globulin therapy.Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpuraIntravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura.Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.Management of immune thrombocytopenic purpura in children: potential role of novel agents.Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions.Positioning new treatments in the management of immune thrombocytopeniaRHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia.Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warning.Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children.Clinical practice: immune thrombocytopenia in paediatrics.Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012How we use WinRho in patients with idiopathic thrombocytopenic purpura.Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study.New aspects on the efficacy of high-dose intravenous immunoglobulins in patients with autoimmune thrombocytopenia.High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura.Emerging drugs for immune thrombocytopenia (ITP).A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach.Management of immune thrombocytopenia: Korean experts recommendation in 2017.
P2860
Q26824798-66BB231A-F60A-4FE5-A243-038BE33F8507Q33378213-214147D6-E9DB-4035-9892-77FE899EC5E3Q33380732-4A71BC49-A987-4FB8-9E70-748F7F398538Q33383108-146EC687-07BC-40DD-853B-B202B96CCB85Q33383303-264EF8AE-DE8C-45E8-BE5A-9A5453B082ECQ33385549-EA654477-7886-4EF5-AA1A-2A1E1C9B045CQ33386303-2FC90AEF-5B76-4C8B-8F43-FF2DAC8C36ECQ33395863-4F1C751E-56F1-433C-BEA0-B2344D8611D4Q33402387-83360149-15AE-4CC3-AEC3-39605DA6261FQ33404095-9971494A-146A-4D35-9EF9-B98AFA7226BDQ33408005-2DA4B08A-30BC-4D35-830A-909A46A1CE0FQ33408781-A0A6E12B-08D9-47D7-ABFC-05194BA98899Q33410356-0101DD59-03BE-42C4-B2F7-CB221D32AB5EQ33412475-97BB5849-ABC6-4D58-9E45-E42957857BC2Q33413038-511F9D9A-9CEF-4682-B0E0-DEA2D39CDA2BQ33423797-1315DD8E-2F40-49A3-9BF3-BE73D20C1B0EQ33427260-5B0A9E99-314A-48CE-B19F-218CD9942558Q33430843-C819F4ED-218D-434F-92F5-6DEB493DAD67Q33437797-2BAB5552-A1CB-43BD-97FF-0CECB37A0EFDQ33439415-97B161C4-09BC-4575-809F-7F3DD663875BQ33439789-44B35673-59CF-46F8-9FED-C2430121DAF9Q36238769-8EDFD27F-C96F-4D32-A802-F340BF1531A3Q41487980-D4FF10DB-4DDE-4A27-BAA2-BF3E110DC09FQ49624514-701F36F0-08E1-4BEE-93C9-6F4044968F09
P2860
Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Single dose of anti-D immune g ...... cytopenic purpura in children.
@ast
Single dose of anti-D immune g ...... cytopenic purpura in children.
@en
type
label
Single dose of anti-D immune g ...... cytopenic purpura in children.
@ast
Single dose of anti-D immune g ...... cytopenic purpura in children.
@en
prefLabel
Single dose of anti-D immune g ...... cytopenic purpura in children.
@ast
Single dose of anti-D immune g ...... cytopenic purpura in children.
@en
P2093
P1476
Single dose of anti-D immune g ...... cytopenic purpura in children.
@en
P2093
Acute ITP Study Group
Diane J Nugent
Frank E Shafer
Henry Lynn
Karen A Kalinyak
Lisa C Weber
Mary L Davis
Michael D Tarantino
Roshni Kulkarni
P304
P356
10.1016/J.JPEDS.2005.11.019
P407
P577
2006-04-01T00:00:00Z